Joanne Kamens

This inventor holds 30 USPTO granted patents and 4 published patent applications, plus 5 CIPO patents and 8 EPO patents. Top assignees: Rxi Pharmaceuticals Corporation, Phio Pharmaceuticals Corp., Rxi Parmaceuticals Corporation. Active years: 2014-2023.

USPTO Granted Patents = 30 (Patent Applications = 4)

% Patents Active = 83.3

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 13)

Average Co-Inventor Count = 5.3

ph-index = 19

Forward Citations = 801(Granted Patents)

Company Filing History:

15 out of 16

Rxi Pharmaceuticals Corporation

patents

14 out of 23

Phio Pharmaceuticals Corp.

patents

1 out of 1

Rxi Parmaceuticals Corporation

patent

Years Active: 2014-2023

Loading Chart...

Areas of Expertise:

RNA Interference

Phosphorothioate Nucleotides

Self-Delivering RNAi

Neutral Nanotransporters

Ocular Indications

Dermal Indications

Fibrotic Indications

MAP4K4 Inhibition

PCSK9 Inhibition

Modified RNAi Polynucleotides

Skin Indications

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11667915 - RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality (2023-06-06),

2. 11584933 - RNA interference in ocular indications (2023-02-21),

3. 11396654 - Neutral nanotransporters (2022-07-26),

4. 11254940 - Inhibition of MAP4K4 through RNAi (2022-02-22),

5. 11118178 - Reduced size self-delivering RNAI compounds (2021-09-14),

6. 10913948 - RNA interference in dermal and fibrotic indications (2021-02-09),

7. 10876119 - Reduced size self-delivering RNAI compounds (2020-12-29),

8. 10815485 - RNA interference in skin indications (2020-10-27),

9. 10774330 - Reduced size self-delivering RNAI compounds (2020-09-15),

10. 10662430 - RNA interference in ocular indications (2020-05-26),

11. 10633654 - Modified RNAi polynucleotides and uses thereof (2020-04-28),

12. 10479992 - RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality (2019-11-19),

13. 10240149 - Reduced size self-delivering RNAi compounds (2019-03-26),

14. 10184124 - RNA interference in ocular indications (2019-01-22),

15. 10167471 - Inhibition of PCSK9 through RNAI (2019-01-01),

Title: Joanne Kamens: Pioneering Inventor from Newton, MA

Introduction: Joanne Kamens is a trailblazing inventor hailing from Newton, MA, known for her groundbreaking contributions to the field of biotechnology and life sciences.

Latest Patents: Joanne Kamens holds several patents in the areas of genetic engineering, personalized medicine, and biopharmaceuticals, showcasing her innovative spirit and dedication to advancing scientific knowledge.

Career Highlights: With a Ph.D. in Genetics from Harvard Medical School, Joanne Kamens has had a remarkable career trajectory, including leadership roles at prominent biotech companies and research institutions. Her work has significantly impacted the development of cutting-edge technologies in the life sciences industry.

Collaborations: Throughout her career, Joanne Kamens has collaborated with top researchers, scientists, and industry experts to drive innovation and bring novel ideas to fruition. Her collaborative approach has led to the successful implementation of numerous projects and initiatives in the biotechnology sector.

Conclusion: Joanne Kamens stands as a pioneering figure in the world of biotechnology, with a passion for innovation and a commitment to pushing the boundaries of scientific discovery. Her contributions continue to inspire future generations of inventors and researchers in the field.